Two Sigma Advisers, LP’s Moderna Inc Position
Does Two Sigma Advisers, LP own Moderna Inc (MRNA)? Not currently — the last reported position was 7.73M shares worth $228M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$228M
Q4 2025
Shares
7.73M
% of Portfolio
+0.44%
Quarters Held
17
position exited
Position History MRNA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 7.73M | $228M | +0.44% |
| Q3 2025 | 6.77M | $175M | +0.35% |
| Q2 2025 | 7.82M | $216M | +0.44% |
| Q1 2025 | 3.81M | $108M | +0.24% |
| Q4 2024 | 103.7K | $4M | +0.01% |
| Q3 2024 | 356.5K | $24M | +0.06% |
| Q1 2024 | 3.5K | $372,960 | 0.00% |
| Q4 2023 | 34.8K | $3M | +0.01% |
| Q2 2023 | 23.9K | $3M | +0.01% |
| Q4 2021 | 14.2K | $4M | +0.01% |
| Q3 2021 | 462.0K | $178M | +0.46% |
| Q2 2021 | 603.9K | $142M | +0.37% |
| Q1 2021 | 157.8K | $21M | +0.06% |
| Q4 2020 | 601.0K | $63M | +0.17% |
| Q3 2020 | 103.2K | $7M | +0.02% |
| Q1 2020 | 7.6K | $228,000 | 0.00% |
| Q2 2019 | 12.6K | $184,000 | 0.00% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Two Sigma Advisers, LP’s full portfolio or all institutional holders of MRNA.